Clinical Trial Protocol for ROSELLA: a phase 3 study of relacorilant in combination with nab-paclitaxel versus nab-paclitaxel monotherapy in advanced platinum-resistant ovarian cancer.
Saved in:
| Title: | Clinical Trial Protocol for ROSELLA: a phase 3 study of relacorilant in combination with nab-paclitaxel versus nab-paclitaxel monotherapy in advanced platinum-resistant ovarian cancer. |
|---|---|
| Authors: | Olawaiye, Alexander B.1 olawaiyea@upmc.edu, Jae-Weon Kim2, Bagameri, Andrea3, Bishop, Erin4, Chudecka-Głaz, Anita5, Devaux, Alix6, Gladieff, Laurence7, Gordinier, Mary E.8, Korach, Jacob9, McCollum, Michael E.10, Mileshkin, Linda11, Monk, Bradley J.12, Nicum, Shibani13, Nogueira-Rodrigues, Angélica14, Oaknin, Ana15, O'Malley, David M.16, Orlando, Mauro17, Dreiling, Lyndah18, Tudor, Iulia C.18, Lorusso, Domenica18 |
| Source: | Journal of Gynecologic Oncology. Jul2024, Vol. 35 Issue 4, p1-10. 10p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
